0001073397-20-000001.txt : 20200601
0001073397-20-000001.hdr.sgml : 20200601
20200601165146
ACCESSION NUMBER: 0001073397-20-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200528
FILED AS OF DATE: 20200601
DATE AS OF CHANGE: 20200601
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LOPEZ GEORGE A
CENTRAL INDEX KEY: 0001073397
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34634
FILM NUMBER: 20934007
MAIL ADDRESS:
STREET 1: C/O ICU MEDICAL
STREET 2: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICU MEDICAL INC/DE
CENTRAL INDEX KEY: 0000883984
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330022692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
BUSINESS PHONE: 949-366-2183
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-05-28
0
0000883984
ICU MEDICAL INC/DE
ICUI
0001073397
LOPEZ GEORGE A
951 CALLE AMANECER
SAN CLEMENTE
CA
92673
1
0
1
0
Common Stock
2020-05-28
4
X
0
6438
43.62
A
346202
D
Common Stock
2020-05-28
4
S
0
16548
197.3739
D
329654
D
Common Stock
2020-05-28
4
S
0
3
198.09
D
329651
D
Common Stock
2020-05-28
4
X
0
10113
46.53
A
339764
D
Common Stock
986843
I
by Partnership
Non-Qualified Stock Option (right to buy)
43.62
2020-05-28
4
X
0
6438
43.62
D
2021-07-20
Common Stock
6438
0
D
Non-Qualified Stock Option (right to buy)
46.53
2020-05-28
4
X
0
10113
46.53
D
2022-02-01
Common Stock
10113
78744
D
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $197.00 to $197.85, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
All shares sold were sold at the exact price disclosed.
Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.
By: Paula Darbyshire, Attorney-in-fact For: George A. Lopez, M.D.
2020-06-01